| | LONDON (Reuters) - GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment. | | | GOSPORT, England (Reuters) - More than 450 patients died prematurely in a British hospital after they were given powerful painkillers with no medical justification, in what a damning report on Wednesday found was a "disregard for human life". | | | (Reuters Health) - Using non-steroidal anti-inflammatory drugs (NSAIDs) around the time of conception significantly increases the risk of miscarriage in the first eight weeks of pregnancy, a study suggests. | | | RAANANA, Israel (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer. | | | COPENHAGEN (Reuters) - Novo Nordisk's experimental diabetes pill, which it hopes will transform the diabetes market, has proved superior to both Merck & Co's Januvia and its own best-selling injectable treatment Victoza in tests. | | | TORONTO (Reuters) - Marijuana sales will become legal in Canada beginning October 17, Prime Minister Justin Trudeau said on Wednesday, making it the first major economy to legalize its recreational use. | | | (Reuters Health) - Older adults who are faster on their feet may be less likely to suffer cognitive problems after heart surgery than patients who have difficulty walking, a Japanese study suggests. | | | (Reuters Health) - Even when the heart rhythm disorder known as atrial fibrillation goes away after treatment, patients' risk of stroke may still be higher than average, a large UK study suggests. | | | GENEVA (Reuters) - Democratic Republic of Congo's Ebola outbreak has been "largely contained" and no new cases of the disease have been confirmed since the last known sufferer died on June 9, the World Health Organization said on Wednesday. | | | (Reuters Health) - Children and adults who take five commonly prescribed types of antibiotics may be more likely to develop kidney stones than people who don't use these medicines, a recent study suggests. | | | | |